1. Home
  2. ATAI vs TG Comparison

ATAI vs TG Comparison

Compare ATAI & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • TG
  • Stock Information
  • Founded
  • ATAI 2018
  • TG 1988
  • Country
  • ATAI Germany
  • TG United States
  • Employees
  • ATAI N/A
  • TG N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • ATAI Health Care
  • TG Industrials
  • Exchange
  • ATAI Nasdaq
  • TG Nasdaq
  • Market Cap
  • ATAI 282.6M
  • TG 264.1M
  • IPO Year
  • ATAI 2021
  • TG 1989
  • Fundamental
  • Price
  • ATAI $1.41
  • TG $8.27
  • Analyst Decision
  • ATAI Strong Buy
  • TG
  • Analyst Count
  • ATAI 3
  • TG 0
  • Target Price
  • ATAI $10.50
  • TG N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • TG 69.5K
  • Earning Date
  • ATAI 05-19-2025
  • TG 05-08-2025
  • Dividend Yield
  • ATAI N/A
  • TG N/A
  • EPS Growth
  • ATAI N/A
  • TG N/A
  • EPS
  • ATAI N/A
  • TG N/A
  • Revenue
  • ATAI $308,000.00
  • TG $617,823,000.00
  • Revenue This Year
  • ATAI $65.58
  • TG N/A
  • Revenue Next Year
  • ATAI N/A
  • TG N/A
  • P/E Ratio
  • ATAI N/A
  • TG N/A
  • Revenue Growth
  • ATAI N/A
  • TG 17.42
  • 52 Week Low
  • ATAI $1.03
  • TG $4.31
  • 52 Week High
  • ATAI $2.57
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • TG 63.47
  • Support Level
  • ATAI $1.36
  • TG $7.67
  • Resistance Level
  • ATAI $1.54
  • TG $8.20
  • Average True Range (ATR)
  • ATAI 0.09
  • TG 0.30
  • MACD
  • ATAI -0.00
  • TG 0.10
  • Stochastic Oscillator
  • ATAI 0.00
  • TG 79.05

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: